Fremanezumab (Synonyms: TEV-48125) |
| Katalog-Nr.GC66408 |
Fremanezumab (TEV-48125) ist ein humanisierter monoklonaler IgG2a-AntikÖrper, der selektiv und stark an Calcitonin Gene-Related Peptide (CGRP) bindet. CGRP ist ein 37 AminosÄuren langes Neuropeptid, das an zentralen und peripheren pathophysiologischen Ereignissen der MigrÄne beteiligt ist. Fremanezumab hat das Potenzial fÜr die Erforschung chronischer MigrÄne.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1655501-53-3
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Fremanezumab (TEV-48125) is a humanized IgG2a monoclonal antibody that selectively and potently binds to calcitonin gene-related peptide (CGRP). CGRP is a 37-amino acid neuropeptide involved in central and peripheral pathophysiological events of migraine. Fremanezumab has the potential for chronic migraine research[1].
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *